|Institutional Source||Beutler Lab|
|Gene Name||ring finger protein 213|
|Is this an essential gene?||Non essential (E-score: 0.000)|
|Stock #||R7680 (G1)|
|Chromosomal Location||119393100-119487418 bp(+) (GRCm38)|
|Type of Mutation||missense|
|DNA Base Change (assembly)||T to C at 119479556 bp|
|Amino Acid Change||Valine to Alanine at position 4728 (V4728A)|
|Ref Sequence||ENSEMBL: ENSMUSP00000091429 (fasta)|
|Gene Model||predicted gene model for transcript(s): [ENSMUST00000093902] [ENSMUST00000131035] [ENSMUST00000172235]|
AA Change: V4728A
|Predicted Effect||probably damaging
AA Change: V4727A
PolyPhen 2 Score 1.000 (Sensitivity: 0.00; Specificity: 1.00)
AA Change: V4727A
|Predicted Effect||probably benign
|Coding Region Coverage||
|Validation Efficiency||100% (53/53)|
FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] This gene encodes a protein containing a C3HC4-type RING finger domain, which is a specialized type of Zn-finger that binds two atoms of zinc and is thought to be involved in mediating protein-protein interactions. The protein also contains an AAA domain, which is associated with ATPase activity. This gene is a susceptibility gene for Moyamoya disease, a vascular disorder of intracranial arteries. This gene is also a translocation partner in anaplastic large cell lymphoma and inflammatory myofibroblastic tumor cases, where a t(2;17)(p23;q25) translocation has been identified with the anaplastic lymphoma kinase (ALK) gene on chromosome 2, and a t(8;17)(q24;q25) translocation has been identified with the MYC gene on chromosome 8. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2011]
PHENOTYPE: Mice homozygous for a knock-out allele exhibit decreased body weight and circulating glucose level but normal glucose tolerance, insulin sensitivity, insulin plasma levels and leptin plasma levels. [provided by MGI curators]
|Allele List at MGI|
|Other mutations in this stock||
|Other mutations in Rnf213||
(F):5'- AGCCATTTGTGGGTACTTAGAG -3'
(R):5'- ATGCCCAGTGACCTGCTATTG -3'
(F):5'- AGAATGAGATGGCCCTTTACCTC -3'
(R):5'- GCTATTGAGCCCTCATCCC -3'